Common Contracts
4 similar License and Sublicense Agreement contracts by OKYO Pharma LTD, Tiziana Life Sciences PLC
LICENSE AND SUBLlCENSE AGREEMENTLicense and Sublicense Agreement • November 10th, 2021 • OKYO Pharma LTD • Biological products, (no disgnostic substances) • Delaware
This License and Sublicense Agreement (“Agreement”) is made effective as of May 22, 2017 (“Effective Date”) by and between on the one hand On Target Therapeutics, LLC, 1S Wynnewood Road, Wellesley, MA 02481 (“On Target” or ‘‘Licensor’’), and Biovitas Capital, 18 South Street, Mayfair, London, W1K 1DG, UK (“Licensee”). Licensor and Licensee are each hereafter referred to individually as a “Party” and together as the “Parties.”
EX-10.2 8 ff12018a1ex10-2_tiziana.htm LICENSE AND SUBLICENSE AGREEMENT RELATING TO CD3 (NI-0401) BETWEEN NOVIMMUNE SA AND TIZIANA LIFE SCIENCES PLC, DATED DECEMBER 2014 LICENSE AND SUBLICENSE AGREEMENTLicense and Sublicense Agreement • May 5th, 2020 • England and Wales
This License and Sublicense Agreement (“Agreement”) is made effective as of December 19th, 2014 (“Effective Date”) by and between on the one hand NovImmune S.A., 14 Chemin des Aulx, 1228 Plan les Ouates, Geneva, Switzerland (“Licensor”), and Tiziana Life Sciences Plc, 18 South Street, Mayfair, London, W1K 1DG, UK (“Licensee”). Licensor and Licensee are each hereafter referred to individually as a “Party” arid together as the “Parties.”
EX-10.3 9 ff12018a1ex10-3_tiziana.htm LICENSE AND SUBLICENSE AGREEMENT RELATING TO IL-6R (NI-1201) BETWEEN NOVIMMUNE SA AND TIZIANA LIFE SCIENCES PLC, DATED DECEMBER 2016 LICENSE AND SUBLICENSE AGREEMENTLicense and Sublicense Agreement • May 5th, 2020 • England and Wales
This License and Sublicense Agreement (“Agreement”) is made effective as of December 22, 2016 (“Effective Date”) by and between on the one hand NovImmune S.A., 14 Chemin des Aulx, Plan les Ouates, Geneva, Switzerland (“Licensor”), and Tiziana Life Sciences, 18 South Street, Mayfair, London, W1K 1DG, UK (“Licensee”). Licensor and Licensee are each hereafter referred to individually as a “Party” and together as the “Parties.”
LICENSE AND SUBLICENSE AGREEMENTLicense and Sublicense Agreement • August 23rd, 2018 • Tiziana Life Sciences PLC • Pharmaceutical preparations • England and Wales
This License and Sublicense Agreement (“Agreement”) is made effective as of December 19th, 2014 (“Effective Date”) by and between on the one hand NovImmune S.A., 14 Chemin des Aulx, 1228 Plan les Ouates, Geneva, Switzerland (“Licensor”), and Tiziana Life Sciences Plc, 18 South Street, Mayfair, London, W1K 1DG, UK (“Licensee”). Licensor and Licensee are each hereafter referred to individually as a “Party” arid together as the “Parties.”
